Drug and Device MDL Update

Dechert LLP
Contact

Several years ago, we decided to try to name the drug and device mass torts.   You know, in case the longest-running products liability MDL is ever the Final Jeopardy answer.  Or, if knowing the largest pharmaceutical MDL to date is something you can use as an ice breaker.  Actually, if you know those things, as my grandmother would say – that and a nickel will get you a cup of coffee (she’s 95 and unfamiliar with Starbuck’s prices).

But, we decided the list was worth updating anyway – including providing links to litigation websites where available.  Let’s start with the ones that are still around since our original post in 2008.  Some are shadows of their former selves; just a few cases hanging on for resolution:

MDL - 986 IN RE: "Factor VIII or IX Concentrate Blood Products" Products Liability Litigation (no website)

MDL-1203 IN RE Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Products Liability Litigation

MDL-1431 IN RE Baycol Products Liability Litigation

MDL-1596 IN RE Zyprexa Products Liability Litigation (no website)

MDL-1626 IN RE Accutane Products Liability Litigation (no website)

MDL-1629 IN RE Neurontin Marketing, Sales Practices and Products Liability Litigation (no website)

Please see full update below for more information.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Dechert LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Dechert LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide